Free Trial
NASDAQ:VCEL

Vericel (VCEL) Stock Price, News & Analysis

$50.11
-1.12 (-2.19%)
(As of 07/19/2024 ET)
Today's Range
$49.29
$51.93
50-Day Range
$41.71
$52.22
52-Week Range
$30.18
$53.14
Volume
364,584 shs
Average Volume
377,896 shs
Market Capitalization
$2.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$51.33

Vericel MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2.4% Upside
$51.33 Price Target
Short Interest
Healthy
7.16% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.54mentions of Vericel in the last 14 days
Based on 26 Articles This Week
Insider Trading
Selling Shares
$3.10 M Sold Last Quarter
Proj. Earnings Growth
354.55%
From $0.11 to $0.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.94 out of 5 stars

Medical Sector

783rd out of 896 stocks

Biological Products, Except Diagnostic Industry

135th out of 151 stocks

VCEL stock logo

About Vericel Stock (NASDAQ:VCEL)

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

VCEL Stock Price History

VCEL Stock News Headlines

Vericel Co. (NASDAQ:VCEL) Insider Sells $782,700.00 in Stock
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
Rare signal predicts 50% market drop - before election
The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.
Sean C. Flynn Sells 15,000 Shares of Vericel Co. (NASDAQ:VCEL) Stock
Vericel (NASDAQ:VCEL) Reaches New 52-Week High on Analyst Upgrade
Vericel (NASDAQ:VCEL) Lowered to "Sell" at StockNews.com
Vericel (NASDAQ:VCEL) PT Lowered to $55.00 at BTIG Research
Vericel Co. (NASDAQ:VCEL) Short Interest Update
See More Headlines
Receive VCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vericel and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2024
Today
7/21/2024
Next Earnings (Confirmed)
8/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:VCEL
Employees
314
Year Founded
1989

Price Target and Rating

Average Stock Price Target
$51.33
High Stock Price Target
$57.00
Low Stock Price Target
$42.00
Potential Upside/Downside
+2.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-3,180,000.00
Pretax Margin
0.61%

Debt

Sales & Book Value

Annual Sales
$197.52 million
Cash Flow
$0.02 per share
Book Value
$4.73 per share

Miscellaneous

Free Float
46,075,000
Market Cap
$2.44 billion
Optionable
Optionable
Beta
1.70

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Dominick C. Colangelo Esq. (Age 60)
    CEO, President & Director
    Comp: $1.54M
  • Mr. Joseph Anthony Mara Jr. (Age 48)
    CFO & Treasurer
    Comp: $750.61k
  • Mr. Michael HalpinMr. Michael Halpin (Age 62)
    Chief Operating Officer
    Comp: $796.91k
  • Mr. Sean C. FlynnMr. Sean C. Flynn (Age 50)
    Chief Legal Officer
    Comp: $657.01k
  • Dr. Jonathan M. Hopper FRCSEd. (Age 62)
    M.B. Ch.B., Chief Medical Officer
    Comp: $672.16k
  • Mr. Jonathan D. Siegal
    Principal Accounting Officer, VP & Corporate Controller
  • Mr. Eric Burns
    Vice President of Finance & Investor Relations
  • Mr. Patrick J. Fowler
    Senior Vice President of Corporate Development & Strategy
  • Mr. Patrick Helfrich
    Vice President of Marketing & Commercial Strategy
  • Mr. Mike Gilligan
    Senior Vice President of Sales

VCEL Stock Analysis - Frequently Asked Questions

How have VCEL shares performed this year?

Vericel's stock was trading at $35.61 at the start of the year. Since then, VCEL stock has increased by 40.7% and is now trading at $50.11.
View the best growth stocks for 2024 here
.

How were Vericel's earnings last quarter?

Vericel Co. (NASDAQ:VCEL) posted its quarterly earnings data on Wednesday, May, 8th. The biotechnology company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.03. Vericel's revenue for the quarter was up 25.0% compared to the same quarter last year.

What is Nick Colangelo's approval rating as Vericel's CEO?

6 employees have rated Vericel Chief Executive Officer Nick Colangelo on Glassdoor.com. Nick Colangelo has an approval rating of 49% among the company's employees. This puts Nick Colangelo in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Vericel's major shareholders?

Vericel's top institutional shareholders include Raymond James & Associates (0.10%), Linden Thomas Advisory Services LLC (0.09%), SG Americas Securities LLC (0.02%) and Juncture Wealth Strategies LLC (0.02%). Insiders that own company stock include Dominick Colangelo, Robert L Md Zerbe, Joseph Anthony Mara Jr, Steven C Gilman, Jonathan Siegal, Michael Halpin, Sean C Flynn and Jonathan Mark Hopper.
View institutional ownership trends
.

How do I buy shares of Vericel?

Shares of VCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Vericel own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vericel investors own include Exelixis (EXEL), Novavax (NVAX), Hello Group (MOMO), Dynavax Technologies (DVAX), Synergy Pharmaceuticals (SGYP), Sorrento Therapeutics (SRNE) and TG Therapeutics (TGTX).

This page (NASDAQ:VCEL) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners